Stockscreener 앱 받기
0.2903
7.35%
-0.0255
전일 마감가:
$0.3158
열려 있는:
$0.31
하루 거래량:
770.54K
Relative Volume:
0.55
시가총액:
$47.13M
수익:
-
순이익/손실:
$-41.23M
주가수익비율:
-0.4147
EPS:
-0.7
순현금흐름:
$-11.54M
1주 성능:
-12.71%
1개월 성능:
-17.02%
6개월 성능:
-41.92%
1년 성능:
-69.84%
1일 변동 폭
$0.2902
$0.3193
1주일 범위
$0.2902
$0.55
52주 변동 폭
$0.285
$2.34
Renovaro Inc Stock (RENB) Company Profile
명칭
Renovaro Inc
전화
45 39179840
주소
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
RENB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.2902 | 52.49M | 0 | -41.23M | -11.54M | -0.70 |
|
ONC
Beigene Ltd Adr
|
235.97 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.81 | 112.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.285 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.07 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
74.14 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Renovaro Inc 주식(RENB)의 최신 뉴스
The Manufacturers Life Insurance Company Makes New $38,000 Investment in Renovaro Inc. (NASDAQ:RENB) - Defense World
Voya Investment Management LLC Acquires Shares of 35,312 Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro launches AI platform to advance neurology drug discovery By Investing.com - Investing.com Nigeria
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform - GlobeNewswire
Renovaro Launches Augusta, an AI-Powered Precision Neurology Pla - GuruFocus
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Barclays PLC - Defense World
Renovaro (REN) Unveils Augusta: A Breakthrough in Precision Neurology | RENB Stock News - GuruFocus
Renovaro BioSciences launches Augusta AI-powered precision neurology platform - TipRanks
Renovaro (REN) Unveils Augusta: A Breakthrough in Precision Neur - GuruFocus
Renovaro launches AI platform to advance neurology drug discovery - Investing.com
Renovaro BioSciences, Amsterdam UMC enter collaboration agreement - TipRanks
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Wells Fargo & Company MN - Defense World
Renovaro partners with Amsterdam UMC on cancer diagnostics - Investing.com
Renovaro and Amsterdam University Medical Center Announce Exclus - GuruFocus
Renovaro partners with Amsterdam UMC on cancer diagnostics By Investing.com - Investing.com India
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics - The Manila Times
Renovaro Inc. and Amsterdam UMC Enter Exclusive Collaboration to Develop Blood Platelet RNA Diagnostics - Nasdaq
Renovaro and Amsterdam University Medical Center Announce - GlobeNewswire
Biotech Tells Chancery Drug Co. Abused Merger Prospects - Law360
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by JPMorgan Chase & Co. - Defense World
Nothing is Better Than Renovaro Inc (RENB) stock at the moment - Sete News
How to interpret Renovaro Inc (RENB)’s stock chart patterns - uspostnews.com
Renovaro Inc’s latest rating changes from various analysts - knoxdaily.com
Renovaro Inc (RENB) Stock: Uncovering 52-Week Market Trends - investchronicle.com
RENB stock touches 52-week low at $0.32 amid market challenges - Investing.com India
Renovaro Inc. (NASDAQ:RENB) Shares Acquired by Geode Capital Management LLC - Defense World
Market Watch: Renovaro Inc (RENB)’s Noteworthy Gain, Closing at 0.37 - DWinneX
Investor’s Delight: Renovaro Inc (RENB) Closes Weak at 0.39, Down -16.49 - DWinneX
AI medicine company Renovaro to use Nebul's AI cloud infrastructure - Data Center Dynamics
Renovaro Inc [RENB] stock for 1,448 USD was sold by William Anderson Wittekind - knoxdaily.com
RENB’s 52-Week Rollercoaster: From $0.32 to $2.34 – What’s Next for Investors? - investchronicle.com
Renovaro BioSciences expands collaboration with Nebul - MSN
Insider’s View: Deciphering Renovaro Inc (RENB)’s Financial Health Through Ratios - DWinneX
Renovaro Inc (RENB)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Renovaro Expands Partnership With Nebul To Accelerate AI-Driven Cancer Diagnostics - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs | RENB Stock News - GuruFocus
Renovaro (ticker) and Nebul Enhance Partnership to Boost Diagnostic Innovations | RENB Stock News - GuruFocus
Renovaro Inc. Expands Collaboration with Nebul to Enhance Early Cancer Detection Through Advanced AI Technology - Nasdaq
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Renovaro's New AI Partnership Targets Breakthrough in Early-Stage Lung Cancer Detection Technology - Stock Titan
Renovaro Inc (NASDAQ: RENB) Has Great Upside Potential - Stocksregister
Renovaro faces Nasdaq delisting over share price issue By Investing.com - Investing.com Canada
Renovaro faces Nasdaq delisting over share price issue - Investing.com
Renovaro Inc. (NASDAQ:RENB) Shares Purchased by Corebridge Financial Inc. - Defense World
Renovaro closes merger transaction with BioSymetrics - Pharmaceutical Business review -
Renovaro merges with BioSymetrics to boost AI drug discovery - Investing.com
Renovaro merges with BioSymetrics to boost AI drug discovery By Investing.com - Investing.com South Africa
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven B - GuruFocus
Walmart stands by its annual financial outlook but pulls back its 1Q view amid tariff uncertainty - The Globe and Mail
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewswire
Major AI Breakthrough: Renovaro-BioSymetrics Merger Creates Powerhouse in Precision Medicine - Stock Titan
Renovaro Inc (RENB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
1.61%
자본화:
|
볼륨(24시간):